Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q1 EPS of ($0.43), $0.02 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $2.35 million versus the consensus estimate of $1.5 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.